We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GP:NASDAQGreenPower Motor Company Inc. Analysis

Data as of 2026-05-23 - not real-time

$1.07

Latest Price

8/10Risk

Risk Level: High

Executive Summary

GreenPower Motor (GP) trades at roughly $1.07, sitting just above the identified support around $0.92 and well below the 200‑day SMA of $1.75, indicating a long‑term downtrend despite a short‑term bullish tilt (20‑day SMA above 50‑day SMA, MACD just turned positive). The RSI sits in the mid‑50s, suggesting neither overbought nor oversold conditions, while volume has been slipping, flagging weakening liquidity. On the fundamentals side, revenue is growing at ~18% with healthy gross and operating margins, yet the company posts a deep net loss, negative EPS, and carries ~$22 M of debt against a market cap of only $5.4 M, resulting in negative book value and a DCF‑derived fair value near $27 – a stark contrast to current pricing. Recent material news reports the resignation of a senior executive, adding short‑term governance uncertainty.
Overall, the stock appears dramatically undervalued relative to its DCF estimate, but the combination of high beta (~1.8), 44% 30‑day volatility, thin trading, and a precarious balance sheet elevates risk. Investors should weigh the upside potential from EV market tailwinds and revenue growth against the immediate liquidity strain and governance concerns.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 3/10

Key Factors

  • Price hovering near technical support
  • Declining trading volume reducing liquidity
  • Executive resignation increasing uncertainty

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • DCF fair value suggests substantial upside
  • Revenue growth outpacing peers
  • Heavy debt load and negative equity limiting upside

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Long‑term EV adoption trends supporting demand
  • Current price far below DCF valuation
  • Potential for balance‑sheet restructuring and profitability improvement

Key Metrics & Analysis

Financial Health

Revenue Growth17.70%
Profit Margin-43.86%
P/E Ratio-2.4
ROA-11.55%
P/B Ratio-1.1
Op. Cash Flow$-2829056
Free Cash Flow$5.8M
Industry P/E29.7

Technical Analysis

TrendNeutral
RSI54.1
Support$0.92
Resistance$1.18
MA 20$1.05
MA 50$1.03
MA 200$1.75
MACDBullish
VolumeDecreasing
Fear & Greed Index91.61

Valuation

Fair Value$26.96
GradeUndervalued
TypeGrowth

Risk Assessment

Beta1.80
Volatility44.49%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.